Mylan Laboratories Limited, (Nashik FDF) recalls
Mylan Laboratories Limited, (Nashik FDF) has 13 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 19 Dec 2018. 13 are still ongoing. The most frequent reason is nitrosamine impurity.
Total recalls 13 since 2018
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 13 latest 19 Dec 2018
Recalls per month, last 24 months click a bar for that month Severity split
0 0%13 100%0 0%
Why mylan laboratories limited, (nashik fdf) is recalled
Ongoing mylan laboratories limited, (nashik fdf) recalls 13 active Reported Class Recall Company Reason Where 19 Dec 2018 Drug CLASS II Amlodipine and Valsartan Tablets, USP 10/320 mg recalled Amlodipine And Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan Tablets, USP 40 mg recalled by Mylan Laboratories Limited Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan and Hydrochlorothiazide Tablets, USP 320/12.5 mg recalled Valsartan And Hydrochlorothiazide Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Amlodipine and Valsartan Tablets, USP 5/320 mg recalled Amlodipine And Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Amlodipine and Valsartan Tablets, USP 5/160 mg recalled Amlodipine And Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan and Hydrochlorothiazide Tablets, USP 80/12.5 mg recalled Valsartan And Hydrochlorothiazide Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide
All mylan laboratories limited, (nashik fdf) recalls, newest first 13 total Reported Class Recall Company Reason Where 19 Dec 2018 Drug CLASS II Amlodipine and Valsartan Tablets, USP 10/320 mg recalled Amlodipine And Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan Tablets, USP 40 mg recalled by Mylan Laboratories Limited Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan and Hydrochlorothiazide Tablets, USP 320/12.5 mg recalled Valsartan And Hydrochlorothiazide Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Amlodipine and Valsartan Tablets, USP 5/320 mg recalled Amlodipine And Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Amlodipine and Valsartan Tablets, USP 5/160 mg recalled Amlodipine And Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan and Hydrochlorothiazide Tablets, USP 80/12.5 mg recalled Valsartan And Hydrochlorothiazide Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan Tablets, USP 160 mg recalled by Mylan Laboratories Limited Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Amlodipine and Valsartan Tablets, USP 10/160 mg recalled Amlodipine And Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan Tablets, USP 80 mg recalled by Mylan Laboratories Limited Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan Tablets, USP 320 mg recalled by Mylan Laboratories Limited Valsartan Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan and Hydrochlorothiazide Tablets, USP 160/12.5 mg recalled Valsartan And Hydrochlorothiazide Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan and Hydrochlorothiazide Tablets, USP 160/25 mg recalled Valsartan And Hydrochlorothiazide Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide 19 Dec 2018 Drug CLASS II Valsartan and Hydrochlorothiazide Tablets, USP 320/25 mg recalled Valsartan And Hydrochlorothiazide Mylan Laboratories Limited, (Nashik FDF) Nitrosamine Impurity Nationwide
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.